|
 |
FludaraThis page contains recent news articles, when available, and an overview of Fludara but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Fludara (when available) Fludarabine is a chemotherapy drug used in the treatment of chronic lymphocytic leukemia. It acts at DNA polymerase alpha, ribonucleotide reductase and DNA primase, results in the inhibition of DNA synthesis, and destroys the cancer cells. For the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen Mechanism Of Action: Fludarabine phosphate is rapidly dephosphorylated to 2-fluoro-ara-A and then phosphorylated intracellularly by deoxycytidine kinase to the active triphosphate, 2-fluoro-ara-ATP. This metabolite appears to act by inhibiting DNA polymerase alpha, ribonucleotide reductase and DNA primase, thus inhibiting DNA synthesis. The mechanism of action of this antimetabolite is not completely characterized and may be multi-faceted. News Articles on Fludarabine Ofatumumab, Fludara®, Cytoxan® Regimen Highly Effective for Initial Treatment ... - 05 Jan 2010 Researchers involved in an international multicenter clinical trial have reported that a regimen of ofatumumab, Fludara® (fludarabine), and Cytoxan® ... Cancer Consultants Arzerraâ„¢, Fludara®, Cytoxan® Combination Effective for Newly Diagnosed CLL - Dec 23, 2009 ...with Fludara® (fludarabine) and Cytoxan® (cyclophosphamide)—FC—is highly effective for previously untreated patients with chronic lymphocytic leukemia. ... Cancer Consultants BioVex Appoints Tim Hanke as VP Commercial Operations - Jan 4, 2010 He began his commercial career at Berlex Laboratories working on the launch of Fludara® for hematological malignancies. OncoVEX GM-CSF is a first in class ... Earthtimes (press release) Treatment Updates - Dec 23, 2009 ...—MW Combining Fludara (fludarabine), Cytoxan (cyclophosphamide), and Rituxan (rituximab) was safer and produced a higher response than pairing Campath ... Curetoday.com (press release) Positive Data on Genzyme's Campath - Dec 10, 2009 Results from the randomized phase III study (CAM314) showed that Campath, when used in combination with Fludara (FluCAM), significantly reduced the risk of ... Zacks.com Drug TherapiesDrug news and recent developments - Dec 23, 2009 The approval was based on a study in which 42 percent of CLL patients who had progressed on Fludara (fludarabine) and Campath (alemtuzumab) responded to ... Curetoday.com (press release) Leucémie lymphoïde chronique : l'émergence d'une nouvelle association de ... - Dec 14, 2009 Elle est souvent traitée par cytostatiques : du cyclophosphamide (Endoxan®), associé ou non à de la fludarabine (Fludara®) pour son effet cytostatique mais ... Destination Santé (Communiqué de presse) Rituxan®-Fludara® Highly Effective for Extranodal MALT B-cell Lymphomas - Nov 9, 2009 Researchers from Spain have reported that Rituxan® (rituximab) and Fludara® (fludarabine) produces complete remissions in 90% of newly diagnosed patients ... Cancer Consultants Arzerraâ„¢ Approved for Refractory Chronic Lymphocytic Leukemia - Nov 2, 2009 ...[4] This study involved 138 patients who were refractory to Fludara and Campath (n=59) or were refractory to Fludara and had bulky disease (n=79). ... Cancer Consultants Research and Markets: This Global Outlook Series on Genetic Engineering ... - Nov 5, 2009 Glycos Partner to Develop Bacterium for Biorefinery * Genzyme Acquires Rights to MabCampath, Fludara and Leukine * Quantel Announces Genetic Engineering ... Reuters Genzyme: Focusing on Lumizyme Approval - Oct 30, 2009 Results were also negatively impacted by the recent acquisition of the full rights to oncology drugs Leukine, Fludara and Campath. ... Seeking Alpha (blog) Genzyme Releases 3Q Financial Results - Oct 26, 2009 Genzyme currently has offices in Beijing and Shanghai, and markets Synvisc, Thymoglobulin and Fludara in China. In addition, Genzyme is building its ... Trading Markets (press release) Genzyme Reports Third-Quarter Financial Results - Oct 22, 2009 Data will be presented from a phase 3 trial of Campath's use in combination with Fludara in relapsed or refractory chronic lymphocytic leukemia patients, ... Business Wire (press release) Genzyme Q3 Profit Falls 87%; Cuts FY09 Earnings Outlook - Update - Oct 21, 2009 The increase was driven by new revenue from Leukine, Campath and Fludara, following the closing of the transaction with Bayer at the end of May. ... Trading Markets (press release) … BioScience gets US FDA approval for generic version of Bayer's... - Oct 17, 2007 Abraxis BioScience Inc said it received US Food and Drug Administration approval for a generic version of Bayer AG's chemotherapy injection Fludara. ... Forbes Cadila launches cancer drug - Jun 9, 2005 Fludara, an orally administered drug, is being introduced for the first time in India and is a product of Berlex Inc, a US affiliate of Schering AG Germany ... Rediff ASCO 2006: Advances in the Treatment of Chronic Lymphocytic … - Jun 2, 2006 Fludara is currently thought to be the most active single agent for the ... 5] These authors stated that Fludara treatment alone is associated with the ... Cancer Consultants … Leukemia; Combination of MabCampath and Fludara shown to be highly... - Jan 11, 2005 Purine analogs, particularly Fludara, have a major impact on the management of CLL, having achieved overall response rates of 60-80% as a single agent in ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Oral formulation of Fludara® approved in Japan - Jan 26, 2007 Fludara® for low-grade non-Hodgkin's Lymphoma and mantle cell lymphoma has received marketing approval in Japan. This new formulation provides a new avenue ... webwire.com Oral Formulation Of Fludara® Approved In Japan - Jan 29, 2007 Bayer Schering Pharma AG announced today that the oral formulation of Fludara® for low-grade non-Hodgkin's Lymphoma and mantle cell lymphoma has received ... Medical News Today - Medical News Today (press release) … Leukemia; Combination of MabCampath and Fludara shown to be highly... - Jan 14, 2005 Purine analogs, particularly Fludara, have a major impact on the management of CLL, having achieved overall response rates of 60-80% as a single agent in ... Pay-Per-View - Genomics & Genetics Weekly - Factiva, from Dow Jones KaloBios Pharmaceuticals Appoints David W. Pritchard as President and... - Oct 12, 2006 Triton developed Betaseron(R) for multiple sclerosis (2005 sales exceed $1 billion), and Fludara(R) for leukemia. He holds an MBA degree from Stanford ... Genetic Engineering News - Genetic Engineering News (press release) International Approvals: Pariet, Fludara Oral, Sandoglobulin NF Liquid - Mar 2, 2007 March 2, 2007 — Japan's Ministry of Health, Labor, and Welfare has approved a new indication for rabeprazole sodium 10-mg tablets, allowing their use as ... Medscape Bayer's oral Fludara gets MHLW approval.(Bayer Schering Pharma)( … - Feb 5, 2007 Bayer Schering Pharma, the health care division of Germany's Bayer AG, says that the oral formulation of its anticancer agent Fludara (fludarabine ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Takeover costs impact Schering's 1st-half 2006. - Jul 31, 2006 Net sales of Fludara (fludarabine), for B-cell chronic lymphocytic leukemia and Campath (alemtuzumab) used to treat leukemia, developed well with respective ... $9.94 - Pharma Marketletter - Alacra Store New standard treatment for the most common form of leukemia in adults - Jul 31, 2007 The drugs used to treat CLL consist of Fludara, Cytoxan and chlorambucil. Recent studies have shown that Fludara in combination with Cytoxan to be the most ... TopCancerNews.com Developments in the Treatment of Chronic Lymphocytic Leukemia and … - Nov 8, 2006 In Fludara® (fludarabine)-refractory CLL patients, Campath® (alemtuzumab) ... Also, in Fludara non refractory patients there was a statistically significant ... Cancer Consultants Study Results Published in Journal of Clinical Oncology Show FluCam … - Oct 21, 2005 ..."When used in combination, Fludara and Campath enhance the benefits seen in ... Purine analogs, particularly Fludara, have had a major impact on the ... biotech-intelligence.com Advances in Treatment of Low-Grade Non-Hodgkin's Lymphoma (NHL): … - Dec 9, 2006 5] They concluded that R-CHOP and R-Fludara combinations were superior to ... In addition, Rituxan/Fludara combinations produced complete remissions in 85% ... Cancer Consultants Radio-Immunotherapy with Zevalin®: Updates from the 2006 American … - Dec 9, 2006 Researchers from Italy evaluated Zevalin consolidation therapy after induction therapy with oral Fludara and Novantrone (FM) in 62 previously untreated ... Cancer Consultants Press Release: Treatment with Subcutaneous (SC) MabCampath(R) ( … - Dec 12, 2005 Seen in Patients Refractory to MabCampath or Fludara Monotherapy ... Oncology, combination therapy with MabCampath (alemtuzumab) and Fludara (fludarabine . ... Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: Xanthus Pharmaceuticals Expands Oncology Pipeline … - Oct 3, 2006 Oral fludarabine is currently marketed by Schering AG in the European Union and Canada under the trade name, Fludara(R), for the treatment of relapsed ... Pay-Per-View - PR Newswire - HighBeam Research Schering AG sees 1st-qtr net profit rise 11%, with strong sales... - May 2, 2005 The company said that "this was mainly due to the patent loss of Fludara (fludarabine) in the USA, which fully impacted our business after the first quarter ... $4.95 - Pharma Marketletter - ECNext Treating cancer with competence, compassion and laughter - Jul 9, 2008 My treatment - a combination of the drugs Rituxan and Fludara - called for five days of injections every 28 days over six months. The final cycle ended last ... $2.00 - Portland Press Herald - NewsBank Custom synthesis of APIs: researchers and process chemists share … - Jan 1, 2008 ..."Leustatin" (cladribine) by Ortho Biotech and "Fludara" (fludarabine phosphate), developed by Berlex Oncology and now owned by Bayer Healthcare (Leverkusen, ... $9.94 - Pharmaceutical Technology - Alacra Store Q2 2005 Schering AG Earnings Conference Call - Final. - Jul 22, 2005 Diane and Fludara sales are impacted by generic competition and declined by 13% ... The effect for Fludara, however, is diminishing and we do expect this to ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Xanthus Pharmaceuticals Expands Oncology Pipeline with Late-Stage … - Oct 3, 2006 NOTE: Fludara(R) is a registered trademark of Schering AG. Contacts:. Kari Watson, MacDougall Biomedical Communications, Inc. - kwatson@macbiocom.com or ... Free with registration - PR Newswire - AccessMyLibrary.com Bayer Schering Pharma integrated in Japan, ranking 18th on the … - Aug 20, 2007 The latter has several anticancer agents, including Fludara IV for chronic lymphatic leukemia, Tasuomin (tamoxifen citrate), a breast cancer agent, ... $4.95 - Pharma Marketletter - ECNext КомпаниÑ? Bayer Schering Pharma AG укреплÑ?ет Ñ?вои позиции на … - Jan 30, 2007 Bayer Schering Pharma AG Ñ?ообщила, что в Японии зарегиÑ?трирован препарат Fludara® длÑ? применениÑ? у пациентов Ñ? неходжкинÑ?кой лимфомой низкой Ñ?тепенью ... ФармацевтичеÑ?кий веÑ?тник Kronisk lymfatisk leukemi - Oct 29, 2007 Klorambucil (Leukeran), fludarabin (Fludara) eller fludarabin (Fludara) i kombinasjon med cyklofosfamid (Sendoxan) er vanlige behandlingsalternativer. ... Rikshospitalet КоммерчеÑ?каÑ? биотехнологиÑ? | Ð?овоÑ?ти биофармы - Feb 9, 2007 За Ñ?чет ингибированиÑ? Ñ?интеза ДÐ?К Fludara Ñ?поÑ?обен тормозить роÑ?Ñ‚ злокачеÑ?твенных клеток. Комитет по медицинÑ?ким продуктам длÑ? иÑ?пользованиÑ? у человека EMEA ... КоммерчеÑ?каÑ? биотехнологиÑ? Press Release: Study Results Published in Journal of Clinical... - Oct 21, 2005 Article: Combination of MabCampath(R) and Fludara(R) Shown to be Highly ... PR Newswire Europe; December 6, 2004 ; 700+ words ... ... effective in treating ... Pay-Per-View - PR Newswire Europe - HighBeam Research ASCO 2008: Highlights of Treatment of Hematological Malignancies - May 30, 2008 Genasense® (oblimersen, Bcl-2 antisense): Researchers involved in a multicenter trial have reported that the addition of Genasense to Fludara® (fludarabine) ... Cancer Consultants Press Release: New Corporate Website Launched - Focus on Life … - Oct 11, 2007 Article: Combination of MabCampath(R) and Fludara(R) Shown to be Highly ... ... Purine analogs, particularly Fludara, have a major ... ... Pay-Per-View - PR Newswire Europe - HighBeam Research Pilules, sirops et cachets: les bons et les mauvais - Jan 21, 2005 Les nouvelles boîtes de Tranxène (moins de comprimés, plus difficiles à extraire de la plaquette) ont été saluées, de même que le Fludara, un anticancéreux, ... Libération `Playing God,' UK Denies Cancer Drugs, Patients Say - May 17, 2007 ...s Taxol for early breast cancer and Bayer AG's Fludara for a type of leukemia. The agency also has issued preliminary opinions that the NHS shouldn't fund ... Bloomberg Press Release: Three Studies Presented at the American Society of … - Dec 9, 2008 PR Newswire; December 10, 2002 ; 700+ words ... ... demonstrate the easy management of B-CLL patients who, after responding to Fludara ... MabCampath. ... Pay-Per-View - PR Newswire - HighBeam Research Drug Combo Effective Against Leukemia - Jul 19, 2007 In the US, patients are often treated with fludarabine (brand name Fludara) or chlorambucil (brand name Leukeran). In the latest study of CLL drugs, ... WebMD Article: JAMA Releases Study Results of the North American Silver- … - Sep 2, 2008 2009 ; 627 words ... ... least a 50 percent overall improvement in progression free survival in the FluCAM arm in comparison to the Fludara arm. ... Pay-Per-View - Wireless News - HighBeam Research La revue « Prescrire » stigmatise « les travers du système actuel d' … - Jan 23, 2005 Quatre produits ont été récompensés pour la qualité du conditionnement : l'anticancéreux Fludara (Laboratoire Schering), la morphine Aguettant, ... €2.00 - LE MONDE - Le Monde Interactif Genta's Stock Slides Again As ODAC Turns Back Genasense - Sep 7, 2006 ...and Fludara (fludarabine, from Schering AG), and physicians also employ Rituxan (rituximab, from Genentech Inc. and Biogen Idec Inc.) on an off-label basis. ... BioWorld Online - BioWorld Online USA pharma: Where have all the blockbusters gone? - Aug 11, 2008 It has, therefore, failed to prove efficacy compared with the more commonly used standard form of care for CLL, which is Bayer's Fludara (fludarabine; ... $34.00 - EIU Country Analysis - Alacra Store Hybrid drugs may help children with leukaemia - Jul 20, 2007 Institute of Cancer Research doctors in Britain found that fludarabine (marketed as Fludara) and chlorambucil (Leukeran), when used together, were no better ... Independent Online å…ˆç?µ2006å¹´ä¸å›½å¸‚场的拓展计划 - Dec 14, 2005 ...å?¦å¤–在2006å¹´å¹´ä¸çš„时候，我们还会有抗肿瘤è?¯æ–¹é?¢çš„产å“?ç¦?è¾¾å?ŽÂ®(Fludara®)çš„å?£æœ?剂型 上市。对我们æ?¥è¯´ï¼Œ2006å¹´çš„é‡?点就是æ??é«˜ä¸´åºŠç ”å?‘的力度，使ä¸å›½çš„消费者å?¯ä»¥å°½æ—© ... æ?œç‹? New Phase III Study Shows Strong Efficacy and Favorable Safety... - Jun 6, 2006 ...therapy and the first product with proven efficacy in CLL patients who have failed both alkylating agents and Fludara (fludarabine phosphate) treatment. ... presseportal.de Clinical Alerts: SPC Changes. - Mar 1, 2008 Fludara tablets (fludarabine phosphate) Statement added that drug is not recommended for use in children. Deltacortril enteric-coated tablets (prednisolone) ... $9.94 - Chemist & Druggist - Alacra Store סל הברי×?ות הב×?: 181 תרופות חדשות - Jan 31, 2005 ...gliadel - טיפול בגידולי מוח, alimta - טיפול במזותלמיה, fludara - טיפול ב-cll ו-aml (סוגי לוקמיה ... NRG מעריב New Phase III Study Shows Strong Efficacy and Favorable Safety... - Jun 5, 2006 ...therapy and the first product with proven efficacy in CLL patients who have failed both alkylating agents and Fludara (fludarabine phosphate) treatment. ... Free with registration - PR Newswire - AccessMyLibrary.com BAYER SCHERING PHARMA AG - Mar 1, 2008 Fludara®, Glucobay®, Magnevist®, Nimotop®, and Ultravist®. BSP's activities are focused on the unmet medical. needs of hemophilia, multiple sclerosis, ... $3,450.00 - GLOBAL INDUSTRY ANALYSTS KEY PLAYERS - Alacra Store Cancer event packs extra meaning; Bruce Tucker - May 12, 2007 He bounced back in 2000 when he became part of a Canadian drug study and was put on a new drug called Fludara. Within days he was back to jogging and, ... Pay-Per-View - The Record - ProQuest Archiver Biopharmaceutical Industry Leader Joins Acologix, Inc. Board of... - Feb 15, 2006 As General Manager of Therapeutics at Berlex, Mr. Robin was responsible for the clinical development and commercialization of drugs such as Fludara(R) for ... Free with registration - PR Newswire - AccessMyLibrary.com Oblimersen Shows Promising Results in Older Patients with Acute … - May 6, 2005 These same researchers previously reported the results of treatment of patients with refractory AML with the combination of Fludara®, cytarabine, ... RxPG NEWS Q1 2006 Schering AG Earnings Conference Call - Final. - Apr 26, 2006 And this was mainly driven by the development of our Hematology products, Fludara and Campath, which both increased by 34%. And it was also influenced by ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Sei casi fatali dopo trattamento con MabCampath nei pazienti con … - May 22, 2008 ...naive al trattamento, sono stati trattati con Fludarabina ( Fludara ) e Rituximab ( Rituxan, Mabthera ), seguiti da Alemtuzumab ( MabCampath ) per il ... XagenaSalute Favrille Announces Appointment of David Guy As Chief Commercial … - Dec 5, 2005 ...to commercializing oncology products and managing leading brands such as Rituxan, Herceptin(R), Fludara(R) and Taxotere(R)," said Dr. Longenecker. ... RedOrbit Active Immunotherapy with FavId® and Leukine® May Be Effective after ... - Dec 9, 2006 One problem that has emerged with vaccine trials has been the impact of the cytoreductive therapy (especially Fludara® (fludarabine) or Rituxan) on the ... Cancer Consultants Alemtuzumab nel trattamento della leucemia linfocitica cronica - Apr 18, 2008 MabCampath è utilizzato nei pazienti cui non si adattano terapie combinate comprendenti Fludarabina ( Fludara ). Ai pazienti devono essere somministrati ... XagenaSalute Lower than Expected Use of Zevalin® and Bexxar® Reported - Jul 14, 2007 The lack of survival data was also given as a cause for low use of Zevalin and Bexxar but such data are also lacking for Fludara® (fludarabine) and Velcade® ... Cancer Consultants Nektar Appoints Howard W. Robin President and CEO - Jan 8, 2007 ...multiple sclerosis and Fludara(R) (fludarabine phosphate) for chronic lymphocytic leukemia, generating annual global sales in excess of $800 million. ... Genetic Engineering News - Genetic Engineering News (press release) CBS Newsman Ed Bradley Dies of CLL Complications - Nov 9, 2006 Nucleoside analogs, such as Fludara (fludarabine) and Leustatin (cladribine), have activity against indolent lymphoid malignancies, including CLL. ... MedPage Today Emerging Therapies for Non-Hodgkin's Lymphoma (NHL): Update from … - Dec 10, 2005 One problem that has emerged has been the impact of the cytoreductive therapy (especially Fludara® (fludarabine) or Rituxan) on the generation of an immune ... Cancer Consultants Diamics Appoints Christine A. Meda as President - Jan 5, 2007 ...and as Medical Affairs Director, responsible for clinical trials for their hematological oncology drugs: Fludara, CamPath and Leukine. ... Genetic Engineering News - Genetic Engineering News (press release) View Current Treatment Options for Chronic Lymphocytic Leukemia (CLL)... - Jul 7, 2006 ...which has achieved significant success when used in combination with fludarabine (Schering AG/Berlex's Fludara, generics) in refractory patients. ... Free with registration - Business Wire - AccessMyLibrary.com Cell Genesys to Present Data From GVAX(R) Cancer Immunotherapy and … - Mar 30, 2006 1398) -- An armed oncolytic vector (OV1203) expressing E. coli purine nucleoside phosphorylase (PNP) combined with Fludara(TM) shows increased efficacy. ... Free with registration - PR Newswire - AccessMyLibrary.com MabCampath effective in B-Cell CLL, says trial.(Leukemia drugs... - Oct 31, 2005 ...developed by USA-based group Genzyme Oncology and Fludara (fludarabine phosphate) and distributed in the USA by Berlex (a subsidiary of Schering AG), ... Free with registration - Pharma Marketletter - AccessMyLibrary.com View Current Treatment Options for Chronic Lymphocytic Leukemia (CLL) - Jul 7, 2006 ...which has achieved significant success when used in combination with fludarabine (Schering AG/Berlex's Fludara, generics) in refractory patients. ... RedOrbit Preliminary Full Year 2005 Schering AG Earnings Conference Call -... - Feb 20, 2006 Here we expect somewhat higher growth rates going forward as the effects from Fludara generics in the US have now washed out in the course of last year. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Therapy in refractory chronic lymphatic leukemia (CLL). - Apr 3, 2006 When the disease becomes refractory, therapy changes from watchful waiting to more aggressive therapy including Fludara (chemo like) and Campath, ... Gerson Lehrman Group Xanthus in-licenses US rights to oral Fludarabine.(Wednesday, Oct. 4) - Oct 9, 2006 Schering reported approximately $133 million in 2005 from global sales of oral and IV fludarabine, which it markets as Fludara. Xanthus intends to schedule ... Free with registration - BioWorld Week - AccessMyLibrary.com Analysis of: Alemtuzumab Compared With Chlorambucil As First-Line … - Dec 10, 2007 Campaths real competitor is not chlorambucil but rather combinations of Fludara or Pentostatin plus Rituxan and an alkylating agents that are somewhat less ... Gerson Lehrman Group Abraxis Pharmaceutical Products, Schaumburg, Ill., (847) 413-2075,... - Dec 10, 2007 The lyophilized version is the generic equivalent of Bayer HealthCare's Fludara for Injection and will be packaged in 50 mg/2 mL single-dose vials. ... Free with registration - Drug Topics - AccessMyLibrary.com Pixanthrone. Different Efficacy than Mitoxanthrone? - Sep 14, 2007 Toxicities have not been worth and prolongation is disease free survival since there are multiple choices for therapy including Rituxan, Fludara, ... Gerson Lehrman Group Excellent Start for Schering AG in 2006. - Apr 26, 2006 Net sales of Fludara(R), Campath(R) and Bonefos(R) developed exceptionally well with increases of over 30%, respectively. Furthermore, Schering AG was very ... Free with registration - PR Newswire - AccessMyLibrary.com University of Ulm; Analysis shows benefit of MabCampath in leukemia - Jan 12, 2005 ...for CLL and the first drug with proven efficacy in CLL patients who have failed both alkylating agents and Fludara (fludarabine phosphate) treatment. ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones STOP PRESS: UK NICE to fast-track major drugs.(United Kingdom. … - Nov 7, 2005 Of these, Eli Lilly's advanced/metastatic breast cancer treatment Gemzar (gemcitabine) and Schering AG's Fludara (fludarabine) for first-line lymphocytic ... $4.95 - Pharma Marketletter - ECNext Leukemia; Analysis shows benefit of MabCampath in leukemia - Jan 15, 2005 ...for CLL and the first drug with proven efficacy in CLL patients who have failed both alkylating agents and Fludara (fludarabine phosphate) treatment. ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Press Release: Cell Genesys to Present Data From GVAX(R) Cancer … - Mar 30, 2006 1398) -- An armed oncolytic vector (OV1203) expressing E. coli purine nucleoside phosphorylase (PNP) combined with Fludara(TM) shows increased efficacy. ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: REVLIMID(R) Clinical Results as Oral Treatment … - Dec 12, 2005 ...in the October issue of the Journal of Clinical Oncology, combination therapy with MabCampath (alemtuzumab) and Fludara (fludarabine phosphate) ... Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: Pharmacyclics Announces Presentation and Publication … - Dec 12, 2005 PR Newswire; December 10, 2002 ; 700+ words ... ... demonstrate the easy management of B-CLL patients who, after responding to Fludara ... MabCampath. ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Research and Markets: Hematological Malignancies - … - May 12, 2005 PR Newswire; December 11, 2002 ; 700+ words ... ... oral formulation of Fludara(R) provides another example of new developments in the disease management of ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Favrille Announces Appointment of David Guy as Chief … - Dec 5, 2005 ...to commercializing oncology products and managing leading brands such as Rituxan, Herceptin(R), Fludara(R) and Taxotere(R)," said Dr. Longenecker. ... Pay-Per-View - PR Newswire - HighBeam Research Derm Dx.(Skin Disorders)(B-cell lymphoma) - Apr 1, 2006 Recent studies have suggested that rituximab (Rituxan) and fludarabine (Fludara) have a greater chemotherapeutic effect on this cancer than commonly used ... Pay-Per-View - Family Practice News - Factiva, from Dow Jones Xanthus In-Licenses US Rights To Oral Fludarabine. - Oct 4, 2006 Schering reported approximately $133 million in 2005 from global sales of oral and IV fludarabine, which it markets as Fludara. ... Pay-Per-View - BIOWORLD Today - Factiva, from Dow Jones BERLEX PUBLISHES LEUKEMIA STUDY RESULTS - Oct 25, 2005 ...combination therapy with Berlex Laboratories' MabCampath (alemtuzumab) and Fludara (fludarabine phosphate) is effective in patients with B-cell chronic ... Pay-Per-View - FDAnews Drug Pipeline Alert - Factiva, from Dow Jones Press Release: Founder of ILEX Oncology and Triton Biosciences, … - Sep 24, 2007 ...for multiple sclerosis, two treatments for chronic lymphocytic leukemia, Fludara(R) and CAMPATH(R), and Clolar(R), a treatment for acute leukemias. ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Genmab to Present Interim Results in Phase I/II... - Aug 22, 2005 ...in the October issue of the Journal of Clinical Oncology, combination therapy with MabCampath (alemtuzumab) and Fludara (fludarabine phosphate) ... Pay-Per-View - PR Newswire Europe - HighBeam Research Article: China Recalls Tainted Leukemia Drugs - AP Online | HighBeam ... - Sep 16, 2007 ...developed by USA-based group Genzyme Oncology and Fludara (fludarabine phosphate) and distributed in the USA by Berlex (a subsidiary of Schering AG), is ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: China Recalls Tainted Leukemia Drugs - AP Online | HighBeam ... - Sep 16, 2007 ...developed by USA-based group Genzyme Oncology and Fludara (fludarabine phosphate) and distributed in the USA by Berlex (a subsidiary of Schering AG), is ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: China Recalls Tainted Leukemia Drugs - AP Online | HighBeam ... - Sep 16, 2007 ...developed by USA-based group Genzyme Oncology and Fludara (fludarabine phosphate) and distributed in the USA by Berlex (a subsidiary of Schering AG), is ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Press Release: TEL2 Gene Cooperates With MYC Gene To Provoke B- … - Mar 21, 2005 CP) and doxorubicin (Dox) in T-cell lymphomas, high efficacy of Fludara and CP ... chemoimmunotherapy in peripheral T-cell lymphomas except primary ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: REVLIMID(R)(lenalidomide) Study In Chronic … - Jun 7, 2005 ...in the October issue of the Journal of Clinical Oncology, combination therapy with MabCampath (alemtuzumab) and Fludara (fludarabine phosphate) ... Pay-Per-View - PR Newswire Europe - HighBeam Research Abraxis gains two FDA OKs for fludarabine. - Oct 22, 2007 The lyophilized version of fludarabine, which is the generic equivalent of Fludara for injection distributed by Bayer HealthCare Pharmaceuticals, ... $4.95 - Pharma Marketletter - ECNext Press Release: Final Data from Phase III Study Show Single-Agent … - Dec 11, 2006 PR Newswire; December 10, 2002 ; 700+ words ... ... demonstrate the easy management of B-CLL patients who, after responding to Fludara ... MabCampath. ... Pay-Per-View - PR Newswire - HighBeam Research Factiva Search - Jan 10, 2005 Chronic Lymphocytic Leukemia; Combination of MabCampath and Fludara shown to be highly effective in CLL. 10 January, 2005 Clinical Oncology Week ... Pay-Per-View - Clinical Oncology Week - Factiva, from Dow Jones Schering AG - Jun 19, 2006 Oncology drugs comprise Fludara for chronic lymphocytic leukemia, Androcur for prostate cancer,. Leukine white blood cell stimulant, Campath monoclonal ... $35.00 - Stock Reports - Standard & Poor's Press Release: Schering AG Maintains Strong Growth Momentum During … - Nov 27, 2006 Net sales of Fludara(R ... respectively. Furthermore, Schering AG was very successful ... PR Newswire. Article: Schering AG: Net Income Increase of 23 Per ... Pay-Per-View - PR Newswire - HighBeam Research Researchers report advances in treatment of leukemia.(Clinical... - Jan 24, 2005 ...has proven efficacy in patients who have failed both alkylating agents and fludarabine (Fludara, Berlex). In fludarabine-refractory CLL, for example, ... Pay-Per-View - Drug Topics - Factiva, from Dow Jones Press Release: Excellent Start for Schering AG in 2006. - PR Newswire... - Apr 26, 2006 Net sales of Fludara(R), Campath(R) and Bonefos(R) developed exceptionally well with increases of over 30%, respectively. Furthermore, Schering AG was very ... Pay-Per-View - PR Newswire - HighBeam Research Research and Markets : Analyze the Financial Performance of Schering ... - Jan 10, 2007 Fludara Operating revenue and cost analysis, 2002-05 Operating revenue/cost analysis Chapter 4. Forecast performance Key findings Introduction ... $4.95 - Business Wire - ECNext Press Release: Data from Phase 3 Trial of Genasense(R) Confirm … - Sep 19, 2005 PR Newswire; December 10, 2002 ; 700+ words ... ... demonstrate the easy management of B-CLL patients who, after responding to Fludara ... MabCampath. ... Pay-Per-View - PR Newswire - HighBeam Research Neue Studie bestätigt höhere Lebenserwartung durch MabCampath(R) ( … - Dec 13, 2005 ...erste Medikament mit bewährter Wirkung bei CLL-Patienten, die weder auf Alkylantien noch die Behandlung mit Fludara ( Fludarabinposphaten) ansprechen. ... presseportal.ch Fludarabin-Kombinationstherapie bei chronisch lymphatischer Leukämie - Apr 14, 2006 Die Deutsche CLL-Studiengruppe hat gezeigt (Blood 2006; 107: 885–891), dass die Kombinationstherapie aus dem Purinanalogon Fludarabin (Fludara®) und dem ... Deutsches Ärzteblatt Regime aus Alemtuzumab und Fludarabin ist effektiv - Aug 1, 2005 In der Studie erhielten 36 CLL-Patienten das FluCam-Regime, bei dem 30 mg / m 2 Fludarabin (Fludara®) und 30 mg Alemtuzumab (Mab Campath®) an drei ... Ärzte Zeitung 복지부 분류코드: 421(í•ì•…ì„±ì¢…ì–‘ì œ) - Apr 9, 2007 ...ë˜?í•œ Fludara는 DNA합성 ì–µì œ ì?´ì™¸ì—?ë?„ RNA polymerase IIì?˜ 부분ì ? ì–µì œë¥¼ 통해 RNA 합성ë?„ ì?¼ë¶€ ì–µì œí•˜ëŠ” 것으로 ë°?혀졌다. 2-fluoro-ara-ATPì?˜ ìž‘ìš©ê¸°ì „ 중 ì?¼ë¶€ëŠ” ... ì•½ì—…ì‹ ë¬¸ Brand Names/Synonyms: Fludara is also known by the following brand names and/or synonymsFAMP; Fludara; Fludarabine; Fludarabine 5'-Monophosphate; Fludarabine Monophosphate; Fludarabine Phosphate; Fludarabine Phosphate [Usan:Ban]; Fludura Drug Category: Fludara is categorized under the following by the FDA: Immunosuppressive Agents; Antimetabolites; Antineoplastic Agents; ATC:L01BB05 Dosage Forms: TABLET; POWDER FOR SOLUTION; IV Solution Absorption: Not Available Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: [5-(6-amino-2-fluoro-purin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxyphosphonic acid |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |